Simulation of Clinical Trias: A Review with Emphasis on the Design Issues

Alessandra Giovagnoli and Maroussa Zagoraiou

Statistica, 2012, vol. 72, issue 1, 63-80

Abstract: Simulation is a widely used tool to investigate real-world systems in a large number of fields, including clinical trials for drug development, since real trials are costly, frequently fail and may lead to serious side effects. This paper is a survey of the statistical issues arising in these simulated trials, with particular emphasis on the design of such virtual experiments, stressing similarities and differences with the design of real trials. We discuss the aims and peculiarities of the simulation models used in this context, including a brief mention of metamodels, and different validating techniques. We illustrate each specific issue through one or more studies recently reported in the medical and/or pharmaceutical literature. We end the paper with some challenging questions on the scientific rigour, ethics and effectiveness of simulation in clinical research, and the interesting research problem of how to integrate virtual and physical experiments in a clinical context.

Date: 2012
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bot:rivsta:v:72:y:2012:i:1:p:63-80

Access Statistics for this article

Statistica is currently edited by Department of Statistics, University of Bologna

More articles in Statistica from Department of Statistics, University of Bologna Contact information at EDIRC.
Bibliographic data for series maintained by Giovanna Galatà ().